Es gab 50 kürzliche Insider-Transaktionen für Lexaria Bioscience Corp. (LEXX), darunter 43 Käufe und 4 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $1.29M und die gesamten Insider-Verkäufe auf $1.4M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Bunka Christopher, Christopher Richard, Docherty John Martin. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — LEXX
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-17 |
Bunka Christopher |
Director |
Schenkung (gegeben) |
100,000 |
- |
- |
273,543 |
| 2025-07-30 |
Bunka Christopher |
Director |
Informierter Kauf |
11,900 |
$0.91 |
$10.87K |
281,912 |
| 2025-07-29 |
Bunka Christopher |
Director |
Informierter Kauf |
15,600 |
$0.92 |
$14.38K |
270,012 |
| 2025-07-29 |
Christopher Richard |
Chief Executive Officer |
Informierter Kauf |
15,000 |
$0.91 |
$13.64K |
65,000 |
| 2025-07-29 |
Docherty John Martin |
President & CSO |
Informierter Kauf |
5,376 |
$0.93 |
$4.99K |
5,376 |
| 2025-07-29 |
Mckechnie William Edward |
Director |
Informierter Kauf |
5,000 |
$0.91 |
$4.53K |
18,191 |
| 2025-07-29 |
Carle Vanessa |
Secretary |
Informierter Kauf |
750 |
$0.91 |
$682.50 |
750 |
| 2025-05-15 |
Bunka Christopher |
Director |
RSU-Zuteilung |
11,000 |
$1.04 |
$11.44K |
184,834 |
| 2025-05-15 |
Reese Albert L Jr |
Director |
RSU-Zuteilung |
11,000 |
$1.04 |
$11.44K |
43,000 |
| 2025-05-15 |
Christopher Richard |
Chief Executive Officer |
RSU-Zuteilung |
150,000 |
$1.04 |
$156K |
350,000 |
| 2025-05-15 |
Baxter Nicholas W |
Director |
RSU-Zuteilung |
11,000 |
$1.04 |
$11.44K |
63,000 |
| 2025-05-15 |
Bhullar Baljinder |
Director |
RSU-Zuteilung |
11,000 |
$1.04 |
$11.44K |
11,000 |
| 2025-05-15 |
Docherty John Martin |
President |
RSU-Zuteilung |
150,000 |
$1.04 |
$156K |
310,834 |
| 2025-05-15 |
Carle Vanessa |
Secretary |
RSU-Zuteilung |
15,000 |
$1.04 |
$15.6K |
75,000 |
| 2025-05-15 |
Shankman Michael Elliot |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$1.04 |
$52K |
100,000 |
| 2025-02-28 |
Christopher Richard |
Chief Executive Officer |
Veräußerung |
200,000 |
$3.92 |
$784K |
- |
| 2025-02-28 |
Shankman Michael Elliot |
Chief Financial Officer |
Unbekannt |
50,000 |
$3.17 |
$158.5K |
- |
| 2025-01-14 |
Bhullar Baljinder |
Director |
Unbekannt |
- |
- |
- |
13,000 |
| 2025-01-07 |
Bunka Christopher |
Director |
RSU-Zuteilung |
100,000 |
- |
- |
373,543 |
| 2024-12-03 |
Christopher Richard |
Chief Executive Officer |
Informierter Kauf |
27,172 |
$2.47 |
$67.17K |
50,000 |
| 2024-12-02 |
Christopher Richard |
Chief Executive Officer |
Informierter Kauf |
22,828 |
$2.24 |
$51.22K |
22,828 |
| 2024-08-12 |
Turkel Catherine C. |
Director |
Informierter Kauf |
1,600 |
$3.13 |
$5.01K |
3,100 |
| 2024-07-31 |
Carle Vanessa |
Secretary |
Informierter Verkauf |
2,567 |
$4.00 |
$10.27K |
- |
| 2024-07-26 |
Reese Albert L Jr |
Director |
RSU-Zuteilung |
12,000 |
$3.39 |
$40.68K |
32,000 |
| 2024-07-26 |
Baxter Nicholas W |
Director |
RSU-Zuteilung |
12,000 |
$3.39 |
$40.68K |
52,000 |
| 2024-07-26 |
Mckechnie William Edward |
Director |
RSU-Zuteilung |
12,000 |
$3.39 |
$40.68K |
52,000 |
| 2024-07-26 |
Turkel Catherine C. |
Director |
RSU-Zuteilung |
12,000 |
$3.39 |
$40.68K |
27,000 |
| 2024-05-14 |
Carle Vanessa |
Secretary |
Optionsausübung |
2,500 |
$1.15 |
$2.88K |
2,567 |
| 2024-04-26 |
Bunka Christopher |
Chief Executive Officer |
RSU-Zuteilung |
49,500 |
$2.36 |
$116.82K |
180,501 |
| 2024-04-26 |
Reese Albert L Jr |
Director |
RSU-Zuteilung |
5,000 |
$2.36 |
$11.8K |
20,000 |
| 2024-04-26 |
Baxter Nicholas W |
Director |
RSU-Zuteilung |
5,000 |
$2.36 |
$11.8K |
40,000 |
| 2024-04-26 |
Docherty John Martin |
President |
RSU-Zuteilung |
49,500 |
$2.36 |
$116.82K |
174,168 |
| 2024-04-26 |
Mckechnie William Edward |
Director |
RSU-Zuteilung |
5,000 |
$2.36 |
$11.8K |
40,000 |
| 2024-04-26 |
Turkel Catherine C. |
Director |
RSU-Zuteilung |
5,000 |
$2.36 |
$11.8K |
15,000 |
| 2024-04-26 |
Carle Vanessa |
Secretary |
RSU-Zuteilung |
10,000 |
$2.36 |
$23.6K |
62,567 |
| 2024-03-15 |
Cabatuan Nelson |
Chief Financial Officer |
Veräußerung |
200,000 |
$2.93 |
$586K |
- |
| 2023-10-26 |
Bunka Christopher |
Chief Executive Officer |
RSU-Zuteilung |
30,000 |
$1.15 |
$34.5K |
131,001 |
| 2023-10-26 |
Docherty John Martin |
President |
RSU-Zuteilung |
30,000 |
$1.15 |
$34.5K |
124,668 |
| 2023-10-26 |
Carle Vanessa |
Secretary |
RSU-Zuteilung |
12,500 |
$1.15 |
$14.38K |
52,567 |
| 2023-07-25 |
Reese Albert L Jr |
Director |
RSU-Zuteilung |
5,000 |
$0.87 |
$4.35K |
15,000 |
| 2023-07-25 |
Baxter Nicholas W |
Director |
RSU-Zuteilung |
5,000 |
$0.87 |
$4.35K |
35,000 |
| 2023-07-25 |
Mckechnie William Edward |
Director |
RSU-Zuteilung |
5,000 |
$0.87 |
$4.35K |
35,000 |
| 2023-07-25 |
Turkel Catherine C. |
Director |
RSU-Zuteilung |
5,000 |
$0.87 |
$4.35K |
10,000 |
| 2023-04-15 |
Downey Gregory |
Chief Financial Officer |
Veräußerung |
4,000 |
$5.04 |
$20.16K |
- |
| 2023-02-09 |
Turkel Catherine C. |
Director |
Informierter Kauf |
1,500 |
$2.84 |
$4.27K |
1,500 |
| 2022-10-14 |
Downey Gregory |
Chief Financial Officer |
RSU-Zuteilung |
121 |
$2.09 |
$252.89 |
1,954 |
| 2022-10-14 |
Downey Gregory |
Chief Financial Officer |
Informierter Kauf |
121 |
$2.09 |
$252.89 |
1,954 |
| 2022-10-13 |
Bunka Christopher |
CEO |
RSU-Zuteilung |
16,600 |
$2.10 |
$34.86K |
254,412 |
| 2022-10-13 |
Bunka Christopher |
Chief Executive Officer |
Informierter Kauf |
16,600 |
$2.10 |
$34.86K |
254,412 |
| 2022-10-12 |
Bunka Christopher |
CEO |
RSU-Zuteilung |
21,900 |
$1.99 |
$43.54K |
237,812 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
